Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
19 hedge funds and large institutions have $22M invested in Miromatrix Medical Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 8 closing their positions.
10% less funds holding
Funds holding: 21 → 19 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
44% less capital invested
Capital invested by funds: $39.1M → $22M (-$17.2M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
+$668K |
| 2 |
FA
Friess Associates
Greenville,
Delaware
|
+$248K |
| 3 |
BlackRock
New York
|
+$139K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$96.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$18.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.86M |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
-$350K |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$291K |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$242K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$160K |
MIRO Hedge Fund Activity: Q3 2021 in Review
19 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q3 2021, worth a combined $22M — down 44% from $39.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MIRO and 6 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was G2 Investment Partners Management, adding an estimated $668K. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $1.86M sold.
- 19 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q3 2021, down from 21 in Q2 2021.
- Funds reported $22M of Miromatrix Medical Inc. Common Stock stock for Q3 2021, down 44% quarter-over-quarter.
- 6 funds opened new Miromatrix Medical Inc. Common Stock positions in Q3 2021 and 8 closed out, a net change of -2 holders.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q3 2021 was G2 Investment Partners Management, an estimated $668K added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q3 2021 was Gilder Gagnon Howe & Co, an estimated $1.86M sold.
Based on aggregated 13F filings for Q3 2021.